Purchases and Sales Made in Q4 2021 in Nrx Pharmaceuticals Inc Wt Exp (NRXPW)
This table provides information about the institutional ownership of Nrx Pharmaceuticals Inc Wt Exp (NRXPW) during Q4 2021. The information is specifically focused on institutions that hold shares of NRX PHARMACEUTICALS INC WT EXP.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 03, 2022
Q4 2021
|
Cambridge Investment Research Advisors, Inc.
|
BUY
|
- |
12.5K+ 73.54% |
$21.7K - $67.9K
|
29.5K
$2.95K
|
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
1.99K+ 83.65% |
$3.45K - $10.8K
|
4.36K
$436
|
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 09, 2022
Q4 2021
|
Yakira Capital Management, Inc.
Westport, CT |
SELL
|
- |
-3K- 10.33% |
$5.22K - $16.3K
|
26K
$2.6K
|
|
|
Feb 14, 2022
Q4 2021
|
Aqr Arbitrage LLC
Greenwich, CT |
SELL
|
- |
-54.3KClosed |
$94.4K - $295K
|
0
$0
|